Proactiveinvestors USA & Canada Caladrius Biosciences Inc https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Caladrius Biosciences Inc RSS feed en Tue, 20 Oct 2020 11:31:54 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Caladrius Biosciences enrolling patients for its coronavirus-induced lung damage treatment study https://www.proactiveinvestors.com/companies/news/931588/caladrius-biosciences-enrolling-patients-for-its-coronavirus-induced-lung-damage-treatment-study-931588.html Thu, 15 Oct 2020 16:05:00 -0400 https://www.proactiveinvestors.com/companies/news/931588/caladrius-biosciences-enrolling-patients-for-its-coronavirus-induced-lung-damage-treatment-study-931588.html Caladrius Biosciences CEO outlines key objectives for its cardiovascular programs in 2020 https://www.proactiveinvestors.com/companies/news/910626/caladrius-biosciences-ceo-outlines-key-objectives-for-its-cardiovascular-programs-in-2020-910626.html Tue, 14 Jan 2020 17:03:00 -0500 https://www.proactiveinvestors.com/companies/news/910626/caladrius-biosciences-ceo-outlines-key-objectives-for-its-cardiovascular-programs-in-2020-910626.html Caladrius Biosciences shares pop after FDA bestows favourable designation on its chronic coronary artery disease treatment https://www.proactiveinvestors.com/companies/news/199165/caladrius-biosciences-shares-pop-after-fda-bestows-favourable-designation-on-its-chronic-coronary-artery-disease-treatment-199165.html Wed, 20 Jun 2018 12:40:00 -0400 https://www.proactiveinvestors.com/companies/news/199165/caladrius-biosciences-shares-pop-after-fda-bestows-favourable-designation-on-its-chronic-coronary-artery-disease-treatment-199165.html Caladrius Biosciences surges as it sells off majority stake in PCT https://www.proactiveinvestors.com/companies/news/175002/caladrius-biosciences-surges-as-it-sells-off-majority-stake-in-pct-175002.html Fri, 17 Mar 2017 14:45:00 -0400 https://www.proactiveinvestors.com/companies/news/175002/caladrius-biosciences-surges-as-it-sells-off-majority-stake-in-pct-175002.html